墨尔本生物医学区（帕克维尔）

A map of Parkville Precinct

Access world-leading biomedical capability, technologies and infrastructure in Melbourne's Biomedical Precinct

Melbourne's Biomedical Precinct is Australia’s, and one of the world’s, leading biomedical centres. The precinct delivers outstanding healthcare, education and world-class research.  It is home to some of the biggest global names in the biomedical sector and is an excellent environment for research based commercial activity.

Melbourne Biomedical Precinct’s cutting edge research and discoveries have resulted in major advances in patient care, disease treatment breakthroughs and development of devices, technologies and medicines that have saved and improved lives in Victoria, Australia and around the world.

It is a place where ideas flourish and where researchers and institutions are both locally and globally connected.  It is a an ideal location for knowledge transfer and innovation.

The Melbourne Biomedical Precinct's research and development infrastructure and vibrant culture make it a highly sought-after destination by global companies and research institutions. We can help you find the right location.

Enquire now

NEWS: A new infectious disease centre to boost Melbourne's Biomedical precinct

Biomedical leaders choose to operate in the precinct.

Successfully leveraging Melbourne's Biomedical Precinct is Australia’s largest pharmaceutical company (CSL), along with some of the biggest global names and niche operators in biomedical research.

  • CSL Limited
  • BioGrid Australia
  • Melbourne Bioinformatics
  • Melbourne Brain Centre
  • Australian Genome Research Facility
  • Bio21 Molecular Science and Biotechnology Institute
  • National Ageing Research Institute

We can connect you with the world-class institutions and research infrastructure available in this precinct.

Invest Victoria can assist you establish valuable connections, research partnerships, or leverage existing state of the art infrastructure.

We can also help you explore opportunities to build and create your own independent infrastructure and research projects within this highly collegiate environment.

The Biomedical Precinct offers access to a high concentration of world-class institutions and research infrastructure, including:

Hospitals

  • The Royal Melbourne Hospital
  • The Royal Children’s Hospital
  • The Royal Women’s Hospital
  • Frances Perry House

Universities

  • University of Melbourne
  • RMIT
  • Monash Institute of Pharmaceutical Science, Monash University

Medical Research Institutes

  • Walter and Eliza Hall Institute
  • Victorian Comprehensive Cancer Centre
  • The Florey Institute of Neuroscience and Mental health
  • Murdoch Children’s Research Institute
  • Peter Doherty Institute for Infection and Immunity
  • Peter MacCallum Cancer Centre
  • CSIRO

The Melbourne Biomedical Precinct is renowned for its cutting-edge research discoveries and improving outcomes.

At a glance

  • Just 2km from Melbourne’s CBD
  • 73,000 people employed across biomedical research, clinical innovation and education
  • $3.6 billion annual economic contribution
  • $1b+ in competitive biomedical research funding secured each year
  • Over 40 globally recognised biomedical organisations co-located within one high-performing precinct
  • 20% of Australia’s health-related patents originate from Parkville institutions
" title="" frameborder="0" width="940" height="529" allowfullscreen>

Parkville Precinct

Why Parkville?

World-class biomedical ecosystem

  • Parkville offers globally unique concentration of research institutes, universities, companies and collaborative infrastructure.
  • A proven track record of innovation, with global companies choosing Parkville to develop and scale biomedical solutions.
  • Dense cluster accelerates partnerships, knowledge sharing, and access to advanced facilities.

Major companies

Major hospitals

Major medical research institutes

Universities

End-to-end biomedical innovation

  • Complete pipeline for biomedical investment – discovery research, clinical trials, product development, biomanufacturing and commercialisation.
  • Leading-edge focus areas include genomics, immunology, cancer, neuroscience, paediatric medicine, infectious diseases and digital health innovation.
  • Central to Australia’s vaccine development and pandemic response.

Access top talent and global networks

  • Home to Australia’s top clinical, scientific and technical professionals.
  • Close links to global research and industry partners, facilitation collaboration and market expansion.
  • Enhanced connectivity with new Parkville Station opened 2025 that links the precinct to Melbourne’s innovation spine, supply chains and customers.

Supportive government policy for Parkville and lifesciences

Recent major investments

Need assistance? We are here to help

We can help you better understand how Parkville Precinct may benefit your business.

Contact us

Frequently Asked Questions (FAQs)